Chr.Hansen Holding A/S
Transactions in connections with share buy-back program
DGAP-News: Chr.Hansen Holding A/S 04.08.2014 / 12:38 --------------------------------------------------------------------- Hoersholm, 2014-08-04 12:38 CEST (GLOBE NEWSWIRE) -- Company announcement no. 33/2014 On 15 January 2014 Chr. Hansen initiated a share buy-back program in compliance with the EU Commission Regulation no. 2273/2003 of 22 December 2003 (the Safe Harbor regulation). The purpose of the share buy-back program is to adjust the capital structure by distributing excess capital to the shareholders. Under the program Chr. Hansen will buy-back shares for an amount of up to EUR 80,000,000 in the period from 15 January 2014 to 22 August 2014. The following transactions have been made under the program in the period 28 July 2014 to 1 August 2014: No. of Shares Average Price, DKK Transaction value, EUR -------------------------------------------------------------------------------- 1: 28 July 2014 22,000 229.98 678,218 -------------------------------------------------------------------------------- 2: 29 July 2014 10,687 231.95 332,279 -------------------------------------------------------------------------------- 3: 30 July 2014 23,668 233.36 740,379 -------------------------------------------------------------------------------- 4: 31 July 2014 21,000 231.61 651,987 -------------------------------------------------------------------------------- 5: 1 August2014 40,000 223.55 1,198,649 -------------------------------------------------------------------------------- Accumulated under the 2,332,302 70,472,212 program -------------------------------------------------------------------------------- Following the above transactions, Chr. Hansen owns a total of 3,634,222 treasury shares corresponding to 2.7% of the issued share capital. For further information, please contact: Anders Mohr Christensen, Senior Director, Investor Relations Tel: +45 4574 7618 About Chr. Hansen Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2012/13 financial year was EUR 738 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen. For further information, please visit www.chr-hansen.com. News Source: NASDAQ OMX --------------------------------------------------------------------- 04.08.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Chr.Hansen Holding A/S Denmark ISIN: DK0060227585 End of News DGAP News-Service --------------------------------------------------------------------- 280614 04.08.2014
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found